pentamethylmelamine has been researched along with altretamine in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (95.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (2.50) | 29.6817 |
2010's | 1 (2.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Ames, MM; Eagan, RT; Kovach, JS; Powis, G | 1 |
Ames, MM; Powis, G | 1 |
Narasimhan, TR; Riley, C; Slavik, J; Slavik, M | 1 |
Borm, PJ; Frankhuyzen-Sierevogel, AC; Noordhoek, J; Weller, EB | 1 |
Clagett-Carr, K; Foster, BJ; Hoth, D; Leyland-Jones, B | 1 |
Abel, G; Graham, MA; Judson, IR; Rutty, CJ | 1 |
Abel, G; Goddard, PM; Harrap, KR; Judson, IR; Newell, DR; Rutty, CJ | 1 |
Abikhalil, F; Atassi, G; Dubois, J; Hanocq, M | 2 |
Hofman, GA; Hulshoff, A; Klippert, PJ; Noordhoek, J | 1 |
Harrap, KR; Muindi, JR; Newell, DR; Smith, IE | 1 |
Hofman, G; Hulshoff, A; Klippert, PJ; Mingels, MJ; Noordhoek, J | 1 |
Hahn, DA | 1 |
Bianchi, M; Catalani, P; Colombo, T; D'Incalci, M; Donelli, MG; Garattini, E; Pantarotto, C | 1 |
Gescher, A; Langdon, SP; Ross, D; Stevens, MF | 1 |
Elserafi, M; Gad-el-Mawla, N; Hamza, R; Khaled, H; Ziegler, JL | 1 |
Broggini, M; Coccia, P; Colombo, T; D'Incalci, M; Garattini, E; Rossi, C | 1 |
Benjamin, RS; Benvenuto, JA; Cabanillas, F; Leavens, M; Loo, TL; Smith, RG; Stewart, DJ | 1 |
Achilli, G; Broggini, M; D'Incalci, M; Garattini, S; Lipartiti, M; Perego, C; Ponzio, F | 1 |
Carter, SK | 1 |
Abel, G; Rutty, CJ | 1 |
Boyd, MR; Dutcher, JS; Jones, RB | 1 |
Goldin, A; Green, D; Morimoto, M; Rahman, A; Schein, PS | 1 |
Begleiter, A; Goldenberg, GJ; Grover, J | 1 |
Benjamin, RS; Benvenuto, JA; Loo, TL; Stewart, DJ | 1 |
Goldberg, RS; Griffin, JP; Krakoff, IH; McSherry, JW | 1 |
Aisner, J; Chiuten, DF; Lichtenfeld, JL; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
Casper, ES; Gordon, C; Gralla, RJ; Jones, BR; Kelsen, DP; Lynch, GR; Woodcock, TM; Young, CW | 1 |
Benjamin, RS; Benvenuto, JA; Loo, TL; Smith, RG; Stewart, DJ | 1 |
McMillan, DR; Ross, CF; Ross, WE | 1 |
Gescher, A; Raymont, C | 1 |
Colombo, T; D'Incalci, M; Torti, L | 1 |
Ames, MM; Sanders, ME; Tiede, WS | 1 |
Broggini, M; Colombo, T; D'Incalci, M; Rossi, C | 1 |
Ajani, JA; Bodey, GP; Cabanillas, FF | 1 |
Harrap, KR; Muindi, JR; Newell, DR; Rutty, CJ | 1 |
Casper, ES; Deesen, PE; Leyland-Jones, BR; Young, CW | 1 |
Broggini, M; Colombo, T; D'Incalci, M; Gescher, A | 1 |
2 review(s) available for pentamethylmelamine and altretamine
Article | Year |
---|---|
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Haplorhini; Humans; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Triazines | 1986 |
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
4 trial(s) available for pentamethylmelamine and altretamine
Article | Year |
---|---|
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Haplorhini; Humans; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Triazines | 1986 |
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Kinetics; Liver; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Nervous System Diseases; Triazines; Vomiting | 1983 |
Randomized phase II trial of hexamethylmelamine versus pentamethylmelamine in carcinoma of the bilharzial bladder.
Topics: Altretamine; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Humans; Nausea; Random Allocation; Schistosomiasis; Time Factors; Triazines; Urinary Bladder Neoplasms | 1984 |
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
36 other study(ies) available for pentamethylmelamine and altretamine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
Topics: Altretamine; Animals; Biological Availability; Drug Evaluation; Humans; Intestinal Absorption; Liver; Male; Neoplasms; Rabbits; Time Factors; Triazines | 1979 |
Determination of pentamethylmelamine and hexamethylmelamine in plasma and urine by nitrogen-phosphorus gas-liquid chromatography.
Topics: Altretamine; Antineoplastic Agents; Chromatography, Gas; Humans; Nitrogen; Phosphorus; Triazines | 1979 |
Changes in serum copper and zinc during treatment with anticancer drugs interfering with pyridoxal phosphate.
Topics: Altretamine; Animals; Antineoplastic Agents; Coenzymes; Copper; Male; Procarbazine; Pyridoxal Phosphate; Rabbits; Triazines; Zinc | 1989 |
Absorption and metabolism of hexamethylmelamine and pentamethylmelamine in rat everted perfused gut segments: correlation with in-vivo data.
Topics: Altretamine; Animals; Antineoplastic Agents; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Kinetics; Male; Muscle, Smooth; Rats; Rats, Inbred Strains; Subcellular Fractions; Triazines | 1985 |
Low central nervous system penetration of N2,N4,N6,-trihydroxymethyl-N2,N4,N6,-trimethylmelamine (Trimelamol): a cytotoxic s-triazine with reduced neurotoxicity.
Topics: Altretamine; Animals; Blood Proteins; Blood-Brain Barrier; Brain; Kinetics; Male; Mice; Mice, Inbred BALB C; Protein Binding; Triazines | 1986 |
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.
Topics: Altretamine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Kinetics; Male; Mice; Mice, Inbred BALB C; Plasmacytoma; Rats; Rats, Inbred Strains; Solubility; Triazines | 1986 |
Pharmacokinetics and metabolism of hexamethylmelamine in mice after IP administration.
Topics: Algorithms; Altretamine; Animals; Chemical Phenomena; Chemistry; Half-Life; Injections, Intraperitoneal; Kinetics; Male; Mice; Models, Biological; Triazines | 1986 |
Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors.
Topics: Altretamine; Animals; Biological Availability; Carcinoma, Renal Cell; Kidney Neoplasms; Male; Mathematics; Mice; Triazines | 1988 |
First-pass metabolism of pentamethylmelamine in the rat liver.
Topics: Altretamine; Animals; Antineoplastic Agents; Biological Availability; Kinetics; Liver; Male; Rats; Rats, Inbred Strains; Triazines | 1985 |
Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.
Topics: Altretamine; Animals; Biological Availability; Chromatography, Gas; Injections, Intra-Arterial; Injections, Intravenous; Intestinal Absorption; Intestine, Small; Intubation, Gastrointestinal; Kinetics; Liver; Male; Rats; Rats, Inbred Strains; Triazines | 1983 |
Hexamethylmelamine and pentamethylmelamine: an update.
Topics: Altretamine; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Leukemia; Lung Neoplasms; Male; Ovarian Neoplasms; Prostatic Neoplasms; Triazines | 1983 |
Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.
Topics: Altretamine; Animals; Antineoplastic Agents; Female; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; Tissue Distribution; Triazines | 1983 |
Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
Topics: Altretamine; Animals; Antineoplastic Agents; Biotransformation; Cell Line; Dealkylation; Female; Formaldehyde; Male; Mice; Mice, Inbred Strains; Triazines | 1984 |
Biochemical studies on the ability of pentamethylmelamine to interact in vivo with DNA and proteins in a sensitive murine ovarian reticular cell sarcoma.
Topics: Altretamine; Animals; Antineoplastic Agents; DNA, Neoplasm; Female; Liver; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Ovarian Neoplasms; Protein Binding; Triazines | 1984 |
Human central nervous system pharmacology of pentamethylmelamine and its metabolites.
Topics: Altretamine; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Glioma; Humans; Kinetics; Melanoma; Triazines | 1983 |
Central side effects of pentamethylmelamine: biochemical and behavioural studies.
Topics: Altretamine; Animals; Biogenic Amines; Body Temperature; Brain; Dopamine; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred C57BL; Motor Activity; Receptors, Dopamine; Spiperone; Triazines | 1984 |
In vitro cytotoxicity of the methylmelamines.
Topics: Altretamine; Animals; Cell Survival; Cells, Cultured; Formaldehyde; Mice; Neoplasms, Experimental; Semicarbazides; Triazines | 1980 |
A sensitive and specific assay for pentamethylmelamine in plasma: applicability to clinical studies.
Topics: Aged; Altretamine; Antineoplastic Agents; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Male; Middle Aged; Neoplasms; Reference Standards; Triazines | 1980 |
Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
Topics: Alkylating Agents; Altretamine; Animals; DNA Replication; DNA, Neoplasm; Leukocyte Count; Male; Mice; Microsomes, Liver; Neoplasms, Experimental; Plasmacytoma; RNA, Neoplasm; Triazines | 1980 |
Uptake and metabolism of hexamethylmelamine and pentamethylmelamine by L5178Y lymphoblasts in vitro.
Topics: Altretamine; Animals; Antineoplastic Agents; Biological Transport; Cell Membrane Permeability; Free Radicals; Kinetics; Leukemia, Experimental; Lymphocytes; Methylation; Mice; Structure-Activity Relationship; Temperature; Triazines | 1980 |
Pharmacology of pentamethylmelamine in humans.
Topics: Altretamine; Biotransformation; Central Nervous System; Humans; Liver; Liver Diseases; Metabolic Clearance Rate; Triazines | 1981 |
Phase I study of pentamethylmelamine.
Topics: Adult; Altretamine; Dose-Response Relationship, Drug; Drug Evaluation; Electroencephalography; Humans; Injections, Intravenous; Leukocyte Count; Myeloproliferative Disorders; Nausea; Neoplasms; Platelet Count; Psychoses, Substance-Induced; Triazines; Vomiting | 1980 |
Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
Topics: Adult; Aged; Altretamine; Anorexia; Central Nervous System; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Triazines; Vomiting | 1980 |
Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Prognosis; Triazines; Vomiting | 1981 |
High-performance liquid chromatographic analysis of pentamethylmelamine and its metabolites in biological fluids.
Topics: Altretamine; Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Kinetics; Metabolic Clearance Rate; Neoplasms; Structure-Activity Relationship; Triazines | 1981 |
Comparison of DNA damage by methylmelamines and formaldehyde.
Topics: Altretamine; Animals; Cells, Cultured; DNA, Neoplasm; Formaldehyde; Leukemia L1210; Mice; Semicarbazides; Triazines | 1981 |
Studies of the metabolism of N-methyl containing anti-tumour agents: 14CO2 breath analysis after administration of 14C-labelled N-methyl drugs, formaldehyde and formate in mice.
Topics: Altretamine; Aminopyrine; Animals; Antineoplastic Agents; Biotransformation; Caffeine; Carbon Dioxide; Formaldehyde; Formates; Male; Mice; Mice, Inbred CBA; Procarbazine | 1981 |
Dose-dependent pharmacokinetics of PMM in the rat.
Topics: Altretamine; Animals; Biotransformation; Kinetics; Male; Rats; Triazines | 1981 |
Metabolic activation of hexamethylmelamine and pentamethylmelamine by liver microsomal preparations.
Topics: Altretamine; Animals; Antineoplastic Agents; Biotransformation; Glutathione; In Vitro Techniques; Male; Microsomes, Liver; NADP; Protein Binding; Rats; Rats, Inbred Strains; Time Factors; Triazines | 1981 |
Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
Topics: Altretamine; Animals; Antineoplastic Agents; Female; Kinetics; Mice; Neoplasms, Experimental; Ovarian Neoplasms; Tissue Distribution; Triazines | 1982 |
Phase I trial of pentamethylmelamine.
Topics: Altretamine; Antineoplastic Agents; Bone Marrow; Central Nervous System; Drug Evaluation; Humans; Neoplasms; Triazines | 1982 |
The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouse.
Topics: Altretamine; Animals; Antineoplastic Agents; Female; Humans; Kinetics; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Species Specificity; Triazines | 1982 |
Specific determination of pentamethylmelamine and its demethylated metabolites in human plasma by high pressure liquid chromatography.
Topics: Altretamine; Chromatography, High Pressure Liquid; Dealkylation; Humans; Kinetics; Triazines | 1982 |
Routes of elimination of hexamethylmelamine and pentamethylmelamine in the rat.
Topics: Altretamine; Animals; Bile; Feces; Male; Rats; Triazines | 1982 |